MPC vs TRDA · P/E 16, rev $138.86B vs P/E 12, rev $210.8M
Marathon Petroleum Corp (MPC) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the MPC and TRDA stock pages for the full models.
Not investment advice.